Abstract
Tuftsin induced tumor necrosis activity was investigated. The activity was found in mice serum several days after i.p. injection of tuftsin. Further experiments with adhering peritoneal and spleen cells indicated that macrophages were the source of the observed activity. The same effect was observed when promyelocytic leukemia cells (HL60) were stimulated with different concentrations of the peptide. These showed yet another possible mechanism for tuftsin antineoplastic activity.
Similar content being viewed by others
References
Adams DO, Hamilton TA: The cell biology of macrophage activation. Ann Rev Immunol 2:283, 1984
Adams DO, Marino P: Activation of mononuclear phagocytes for destruction of tumor cells as a model for study of macrophage development: In: AS Gordon, J Silber and J Lobue (eds). Contemporary topics in Hematology-Oncology. Plenum Publishing Corporation, New York, 1983, p 102
Adams DO, Nathan CF: Molecular mechanisms operative in cytolysis of tumor cells by activated macrophages. Immunol Today 4:166, 1983
Aggarwal BB, Kohr WJ, Hass E, Moffat B, Spencer SA, Henzel WJ, Bringman TS, Nedwin GE, Goeddel DV, Harkins RN: Human tumor necrosis factor. J Biol Chem 200:2345, 1985
Beretz A, Hiller Y, Gottlieb P, Fridkin M, Zakuth V, Spirer Z: In: S Sakakibara (ed). Peptide Chemistry. Protein Research Foundation, Osaka, Japan, 1983, p 207
Beutler B, Greenwald D, Hulmes JD, Chang M, Pan YC, Mathison J, Ulenteh R, Cerami A: Identity of tumor necrosis factor and the macrophage secreted factor cachectin. Nature 316:552, 1985
Beutler B, Mahoney J, Le Trang N, Pekala P, Cerami A: Purification of cachectin, a lipoprotein — lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med 161:984, 1985
Boraschi D, Censini S, Tagliabue A: Macrophage antitumor activity. Eur J Immunol 14:1061, 1984
Bruley-Rosset M, Hercend T, Rappaport H, Mathé G: Immuno-restorative capacity of tuftsin after long-term administration to aging mice. Ann NY Acad Sci 419:242, 1983
Carswell EA, Old LJ, Nassel RL, Green S, Fiore N, Williamson B: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666, 1975
Catane R, Schlanger S, Weiss L, Penchas S, Fuks Z, Treves AJ, Gottlieb P, Fridkin M: Toxicology and antitumor activity of tuftsin. Ann NY Acad Sci 419:251, 1983
Catane R, Sulkes A, Uziely B, Gez E, Isacson R, Treves AJ, Fridkin M: Initial clinical studies with tuftsin. Drugs Exp Clin Trials in press 1986
Chaudhuri MK, Najjar VA: Solid phase tuftsin (Thr-Lys-Pro-Arg) synthesis: deprotection and resin cleavage with trifluoromethane sulfonic acid. Anal Biochem 95:305, 1979
Coley WB: Treatment of inoperable malignant tumors with toxins of erysipelas and Bacillus prodiosus. Am J Med Sci 108:50, 1984
Collins SJ, Gallo RC, Gallagher RE: Continuous growth and differentiation of human myeloid leukemia cells in suspension culture. Nature 270:374, 1977
Evans ChH: Lymphotoxin — an immunologic hormone with anticancerogenic and antitumor activity. Cancer Immunol Immunother 12:181, 1982
Florentin I, Bruley-Rosset M, Kiger N, Imbach JL, Winternitz F, Mathé G: In vivo immunostimulation by tuftsin. Cancer Immunol Immunother 5:211, 1978
Florentin I, Martinez J, Maral J, Pelletier M, Chung V, Roch-Arveiller M, Bruley-Rosset M, Giroud MP, Winternitz F, Mathé G: Immunopharmacological properties of tuftsin and of some analogues. Ann NY Acad Sci 419:177, 1983
Haranaka K, Satomi N: Cytotoxic activity of tumor necrosis factor (TNF) on human cancer cells in vitro. Jap J Exp Med 51:191, 1981
Haranaka K, Satomi N, Sakurai A: Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int J Cancer 34:263, 1984
Haranaka K, Satomi N, Sakurai A, Haranaka R: Role of first stimulating agents in the production of tumor necrosis factor. Cancer Immunol Immunother 18:87, 1984
Helson L, Helson C, Green S: Effect of murine tumor necrosis factor on heterotransplanted human tumors. Expl Cell Biol 47:53, 1979
Hoffmann MK, Oetgen HF, Old LJ, Mittler RS, Hammerling U: Induction of immunological properties of tumor necrosis factor. J Reticuloendoth Sec 23:307, 1978
Johnson WJ, Somers SD, Adams DO: Activation of macro for tumor cytotoxicity. Comtemp Top Immunobiol 14:127, 1983
Kavai M, Lukacs K, Szegedi G, Szekerke M, Erchegyi J: Chemotactic and stimulating effect of tuftsin and its analogues on human monocytes. Immunol Lett 2:219, 1981
Konopińska D, Luczak M, Wleklik M, Gumulka S, Kazanowska B: Elongated tuftsin anaologues — synthesis and biological investigation. Ann NY Acad Sci 419:35, 1983
Knyszynski A, Gottlieb P, Fridkin M: Inhibition by tuftsin of Rauscher virus leukemia development in mice. J Natl Cancer Inst 71:87, 1983
Kumagi K, Itoh K, Hinuma S, Tado M: Pretreatment of plastic petri dishes with fetal calf serum: A simple method for macrophage isolation. J Immunol Meth 29:17, 1979
Lachmann P: Tumor immunology: a review. J R Soc Med 77:1023, 1984
Mannel DN, Moore RN, Mergenhagen SE: Macrophage as a source of tumoricidal activity (Tumor Necrotizing Factor). Infect Immun 30:523, 1980
Mathews N: Production of an anti-tumor cytotoxin by human monocytes. Immunobiology 44:135, 1981
Martinez J, Winternitz F, Vindel J: Nouvelles synthèses et propriétés de la tuftsine. Eur J Med Chem Chim Ther 12:511, 1977
Mathews N: Tumor necrosis factor from the rabbit: II: Production by monocytes. Br J Cancer 38:310, 1978
Najjar VA: Tuftsin (Thr-Lys-Pro Arg) a natural activator of phagocytic cells with antibacterial and antineoplastic activity. In: PF Torrence (ed). Biological Response Modifiers. Academic Press, Inc, New York, 1985, p 141
Najjar VA, Bump NJ: Tuftsin (Thr-Lys-Pro-Arg) a stimulation of all known functions of macrophage. In: RL Fenichel and MA Chirigos (eds). Immune Modulation Agents and Their Mechanisms. Marcel Dekker, Inc, New York, 1984, p 229
Najjar VA, Chaudhuri MK, Konopińska D: Tuftsin (ThrLys-Pro-Arg) a physiological activator of phagocytic cells: A possible role in cancer suppression and therapy. In: EM Hersh, MA Chirigos and MJ Mastrangelo (eds). Augmenting Agents in Cancer Theraphy. Raven Press, New York, 1981, p 459
Najjar VA, Constantopoulos A: A new phagocytosis-stimulating tetrapeptide hormone, tuftsin and its role in disease. J Reticuloendothel Soc 12:197, 1972
Najjar VA, Linehan L, Konopińska D: The antineoplastic effects of tuftsin and tufsinyltuftsin on B16/5B melanoma and L1210 cells. Ann NY Acad Sci 419:261, 1983
Najjar VA, Konopińska D, Chaudhuri MK, Schmidt DE, Linehan L: Tuftsin, a natural activator of phagocytic functions including tumoricidal activity. Mol Cell Biochem 41:3, 1981
Najjar VA, Nishioka K: Tuftsin — a physiological phagocytosis stimulating peptide. Nature 228:672, 1970
Nishioka K: Anti-tumour effect of the physiological tetrapeptide tuftsin. Br J Cancer 39:342, 1979
Nishioka K, Amoscato AA, Babcock GF: Tuftsin: A hormone-like tetrapeptide with antimicrobial and antitumor activities. Life Sci 28:1081, 1980
Nishioka K, Babcock GF, Phillips JH, Banks RA, Amoscato AA: In vivo and in vitro antitumor activities of tuftsin. Ann NY Acad Sci 419:234, 1983
Nishioka K, Constantopoulos A, Satoh P, Mitchell W, Najjar VA: Characteristics and isolation of the phagocytosisstimulating peptide, tuftsin. Biochim Biophys Acta 310:217, 1973
Nishioka K, Satoh PS, Constantopoulos A, Najjar VA: The chemical synthesis of the phagocytosis stimulating tetrapeptide — tuftsin (Thr-Lys-Pro-Arg) and its biological properties. Biochim Biophys Acta 310:230, 1973
Nissen-Meyer J, Hammerstrom J: Physicochemical characterization of cytostatic factors released from human monocytes. Infect Immun 38:67, 1982
Pennica D, Medwin GE, Hayflick JS, Seeburg PM, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV. Human tumor necrosis factor: precursor, structure, expression and homology to lymphotoxin. Nature 312:724, 1984
Ruco LP, Meltzer MS: Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short lived intermediary reactions. J Immunol 121:2035, 1978
Ruff MR, Gifford GE: Rabbit tumor necrosis factor: mechanism of action. Infect Immun 31:380, 1981
Shear MJ: Chemical treatment of tumors: IX: Reactions of mice with primary subcutaneous tumors to injection of a hemorrhage producing bacterial polysachharide. J Natl Cancer Inst 4:461, 1944
Shirai T, Yamaguchi H, Ito H, Todd ChW, Wallace B: Cloning and expression in E: coli of the gene for human tumor necrosis factor. Nature 313:803, 1985
Snyama K, Goldstein J, Green S: Effects of murine tumor necrosis factor on friend erythroleukemic cells. Expl Cell Biol 53:85, 1985
Tzehoval E, Segal S, Stabinsky Y, Fridkin M, Spirer Z, Feldman M: Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: General implication to activation of programmed cells. Proc Natl Acad Sci USA 75:3400, 1978
Umeda T, Hara T, Niijima T. Cytotoxic effect of tumor necrosis factor on human lymphocytes and specific binding of the factor to the target cells. Cell Mol Biol 29:349, 1983
Wang AM, Creasey AA, Ladnen MB, Lin LS, Strickler J, Van Arsdell JN, Yamamoto R, Mark DF: Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 228:149, 1985
Wleklik M, Luczak M, Najjar VA: In Symposium Abstracts Polish Society of Virology: Lodz, Poland, in press 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wleklik, M.S., Luczak, M. & Najjar, V.A. Tuftsin induced tumor necrosis activity. Mol Cell Biochem 75, 169–174 (1987). https://doi.org/10.1007/BF00229905
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00229905